Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in Italy / NCT04976712
Recruiting Observational

Core Temperature in Patients With OHCA

NCT04976712 · tracked via the Priya Life Science Italy tracker
Sponsor
Azienda Sanitaria dell'Alto Adige
Phase
Observational
Started
2021-07-01
Last updated
2026-08-11

Condition(s) studied

Out-Of-Hospital Cardiac ArrestAccidental HypothermiaTemperature Change, Body

Study summary

A prospective observational study aiming to monitor core temperature via an esophageal probe in out of hospital cardiac arrest during transport and until arrival in hospital. Insertion of an esophageal temperature probe will be done on scene during ongoing resuscitation manoeuvres based on European Resuscitation Council Guidelines 2015 (or newer). Environmental temperature influence and hypothermia prevention interventions will be monitored.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Out of hospital cardiac arrest * Patients transferred to hospital * \> 18 years Exclusion Criteria: * Obvious signs of death * Obvious lethal injury/injuries incompatible with life * Confirmation of death on scene * \< 18 years

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Bruneck Regional Hospital Bruneck Italy Recruiting

More Azienda Sanitaria dell'Alto Adige trials in Italy

Multimodal Assessment of Cryotherapy for Paclitaxel-Induced Neuropathy Recruiting

Other trials for the same condition

Compression Only CPR Versus Standard CPR in Out-Of-Hospital Cardiac Arrest - A Randomized Survival Study Recruiting
International Registry of Accidental Hypothermia Recruiting
Prehospital Resuscitation Intranasal Cooling Effectiveness Survival Study 2 Recruiting
Technological and Patient-tailored Innovations for Maximizing Effectiveness of Cardiac Arrest Resuscitation Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT04976712 on ClinicalTrials.gov ↗ ← All trials in Italy